Streetbeat News

Earnings

ASND

Ascendis Pharma's shares declined following disappointing Q2 sales results and a reduction in FY24 revenue guidance for its SKYTROFA product.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:44 am

DAKT

Daktronics reported a Q1 2025 GAAP EPS loss of $(0.11) and sales of $226.088 million, missing the analyst estimate of $229.071 million. This represents a decrease from $232.531 million in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:43 am

CRMT

America's Car-Mart reported a Q1 EPS loss of $(0.15), missing the consensus estimate of $0.66, and a significant decrease from last year's $0.63 EPS. However, sales of $347.76M beat the estimate of $338.78M.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:39 am

ZS

Zscaler shares are trading lower after the company reported its Q4 earnings. Additionally, Needham and Baird have both lowered their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:37 am

HRL

Hormel Foods shares declined following the release of mixed Q3 financial results and a reduction in FY24 sales guidance, with the midpoint falling below analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:35 am

CNM

Core & Main has revised its 2024 financial outlook due to weather disruptions and lower-than-expected market volumes. The company now expects net sales of $7.3B-$7.4B and adjusted EBITDA of $900M-$930M, down from previous estimates. Despite these challenges, Core & Main remains optimistic about long-term demand and has improved its operating cash flow conversion range.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:34 am

CECO

ESTC

USPH

The article highlights notable insider trades in three companies: Elastic, U.S. Physical Therapy, and CECO Environmental. Insider purchases can indicate confidence in a company's prospects. Elastic's director bought $1.48M worth of shares after strong earnings. U.S. Physical Therapy's director purchased shares despite downbeat earnings. CECO Environmental's director and CEO made significant purchases following a revenue guidance increase.

Portfolio Pulse from Avi Kapoor

September 04, 2024 | 11:34 am

CNM

Core & Main reported Q2 2024 earnings per share of $0.61, missing the analyst estimate of $0.73. Sales were $1.964 billion, below the expected $2.059 billion, but up 5.53% from last year.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:32 am

NVDA

SPY

USO

U.S. stocks experienced a significant decline, with the S&P 500, Nasdaq, and Dow seeing their steepest losses since early August. Nvidia's sharp drop of nearly 10% contributed to the broader market decline. Weaker manufacturing data and uncertainty over Federal Reserve interest rate cuts dampened investor sentiment. Most S&P 500 sectors fell, particularly energy, tech, and communication services, while real estate and consumer staples gained. Asian and European markets also saw declines, and crude oil prices fell below $70.

Portfolio Pulse from Akanksha Bakshi

September 04, 2024 | 11:26 am

HRL

Hormel Foods Corporation (NYSE:HRL) revised its FY24 outlook due to production disruptions, causing its stock to drop. Despite beating EPS estimates, sales missed expectations, and the company faces challenges in its Retail and International segments. Hormel anticipates continued growth in its Foodservice segment and improvements in its supply chain.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 11:25 am